What Bosses Really Think of Remote Workers govexec.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from govexec.com Daily Mail and Mail on Sunday newspapers.
Rensselaer algorithm can identify risk of cardiovascular disease using lung cancer scan
Heart disease and cancer are the leading causes of death in the United States, and it’s increasingly understood that they share common risk factors, including tobacco use, diet, blood pressure, and obesity. Thus, a diagnostic tool that could screen for cardiovascular disease while a patient is already being screened for cancer has the potential to expedite a diagnosis, accelerate treatment, and improve patient outcomes.
In research published today in Nature Communications, a team of engineers from Rensselaer Polytechnic Institute and clinicians from Massachusetts General Hospital developed a deep learning algorithm that can help assess a patient’s risk of cardiovascular disease with the same low-dose computerized tomography (CT) scan used to screen for lung cancer. This approach paves the way for more efficient, more cost-effective, and lower radiation diagnoses, without requiring patients t
Share this article
Share this article
ResearchAndMarkets.com s offering.
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across retinal diseases, viral and non-viral vector platforms for gene therapies, allogeneic cell therapy, bone repair, gluten antigen-specific drug therapy for Celiac disease, plant-based anti-cancer agents, and food colors. Further, PCR-free whole genome sequencing, oral protein-drug delivery technology for insulin, and cryo transmission electron microscope for viral protein analysis are discussed.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
Interview with the President and CEO: Iron Mountain Incorporated (NYSE:IRM)
William Meaney is President and Chief Executive Officer of Iron Mountain Incorporated and serves as a Director on the company’s board. He previously served as CEO of The Zuellig Group, a $12 billion primarily business-to-business conglomerate based in China Hong Kong S.A.R. Prior to leading The Zuellig Group, Mr. Meaney spent a number of years in the airline industry, serving as the Chief Commercial Officer and Managing Director of publicly traded Swiss International Airlines from December 2002 to January 2004 and Executive Vice President of South African Airways from 1998 to 2001. Earlier in his career, Mr. Meaney served as the acting CEO of South African Vaccine Producers; the founder and Managing Director of Genhro Management Consultancy; and a Principal of Strategic Planning Associates, now part of Oliver Wyman. His first career was as a CIA operations officer. Mr. Meaney is a member of the Asia Busi
Riveros Promoted to Senior VP Post at PAC Worldwide
News provided by
Share this article
Share this article
SEATTLE, May 20, 2021 /PRNewswire/ Flexible packaging leader PAC Worldwide announces the promotion of Misha Riveros to Senior Vice-President of Engineering. PAC President Steve Foster made the announcement from the global company s Seattle headquarters.
A packaging and manufacturing executive whose career spans both domestic and overseas assignments, Ms. Riveros assumes her new role after leading PAC Worldwide s innovation programs for much of the past year. She will be responsible for spearheading the engineering group s R&D, design, and production operations as the company strives to meet increasing market demand for its diverse packaging products and solutions.